Eva Muehlhofer

8PUBLICATIONS
28CO-AUTHORS
Exercise physiologyPharmacogenomicsRespiratory diseasesCardiovascular medicine and haematology not elsewhere classifiedShip and platform structures (incl. maritime hydrodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.

Mario Enrico Canonico, Jessica Parr, E Sebastian Debus

|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Shea Hogan, Michael Szarek, E Sebastian Debus

|May 06, 2024
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.

Justin T Morrison, Mario Enrico Canonico, Sonia S Anand

|Feb 20, 2024
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.

Shea E Hogan, Eike Sebastian Debus, Mark R Nehler

|Oct 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.

Jennifer Rymer, Sonia S Anand, E Sebastian Debus

|Jun 21, 2022
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.

Nana Pogosova, Jacqueline Bosch, Deepak L Bhatt

Pageof 2

Frequent Collaborators

7 joint publications

Scott E Berkowitz

7 joint publications

Manesh R Patel

7 joint publications

Sonia S Anand

7 joint publications

Marc P Bonaca